Abstract
Patients affected by Klinefelter syndrome (KS) have higher cardiovascular mortality due to both acquired cardiovascular disease and congenital heart malformation. Metabolic syndrome and type 2 diabetes, which are highly prevalent in KS patients, may contribute to the increased cardiovascular mortality. The few available studies on cardiac damage in KS have provided conflicting results. Aside from increased prevalence of valvular abnormalities, such as mitral valve prolapses, studies have shown that KS is associated with left ventricular morpho-functional alterations. Additionally, KS is also associated with worse exercise performance, subclinical atherosclerosis, and endothelial dysfunction. A dedicated cardiovascular work-up, mainly through echocardiographic exam, has been suggested in the management of KS patients, aiming to reduce the cardiovascular risk by early diagnoses of preclinical and clinical abnormalities. More research is needed to better characterize the cardiovascular features in KS, to elucidate the pathophysiological mechanisms underlying the increased cardiovascular risk, and to define the contribution of testosterone replacement in restoring cardiovascular health in KS patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bojesen A, Juul S, Birkebaek N, Gravholt CH. Increased mortality in Klinefelter syndrome. J Clin Endocrinol Metab. 2004;89(8):3830–4.
Swerdlow AJ, Higgins CD, Schoemaker MJ, Wright AF, Jacobs PA, United Kingdom Clinical Cytogenetics Group. Mortality in patients with Klinefelter syndrome in Britain: a cohort study. J Clin Endocrinol Metab. 2005;90(12):6516–22.
Bojesen A, Juul S, Birkebaek NH, Gravholt CH. Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses. J Clin Endocrinol Metab. 2006;91(4):1254–60.
Adatia I, Coe JY, Harder J. Transposition of the great arteries in a neonate with Klinefelter’s syndrome. Pediatr Cardiol. 1987;8(4):285–6.
Liu J, Moulick A, Mesia CI, Ge S, Obiri N, Anderson CE. Transposition of the great arteries in a neonate with Klinefelter syndrome-an incidental finding or a true association. Am J Med Genet A. 2015;167A(1):268–70.
Velagaleti GV, Kumar A, Lockhart LH, Matalon R. Patent ductus arteriosus and microdeletion 22q11 in a patient with Klinefelter syndrome. Ann Genet. 2000;43(2):105–7.
Zhang Y. Congenital defect of the partial atrioventricular canal with Klinefelter syndrome. BMJ Case Rep. 2009;2009:bcr10.2008.1121.
Gautier M, Nouaille J. [Systematic study of the Barr body in 500 infants with severe congenital heart diseases]. Arch Fr Pediatr. 1967;24(1):109.
Yoshida K, Ryu T, Ogata T, Tsuji S, Tokushima T, Utsunomiya T, et al. An elderly man with Klinefelter syndrome associated with hypertrophic cardiomyopathy, sick sinus syndrome, and coronary arteriovenous fistula. Jpn Circ J. 1998;62(3):222–4.
Agarwal S, Dekam MJ. Multiple cardiac anomalies in an elderly man with Klinefelter’s syndrome. Singapore Med J. 2011;52(1):e15–7.
Peet J, Weaver DD, Vance GH. 49,XXXXY: a distinct phenotype. Three new cases and review. J Med Genet. 1998;35(5):420–4.
Hou JW. 49, XXXXY syndrome. Chang Gung Med J. 2004;27(7):551–4.
Shen Z, Zou CC, Shang SQ, Jiang KW. Down-Klinefelter syndrome (48,XXY,+21) in a child with congenital heart disease: case report and literature review. Intern Med. 2012;51(11):1371–4.
Hustinx TW, Eberle P, Geerts SJ, ten Brink, Woltring LM. Mongoloid twins with 48 chromosomes (AA plus A21XXY). Ann Hum Genet. 1961;25:111–5.
Serra W, De Iaco G, Reverberi C, Gherli T. Pulmonary embolism and patent foramen ovale thrombosis: the key role of TEE. Cardiovasc Ultrasound. 2007;5:26.
Hecht F, Nievaard JE, Duncanson N, Miller JR, Higgins JV, Kimberling WJ, et al. Double aneuploidy: the frequency of XXY in males with Down’s syndrome. Am J Hum Genet. 1969;21(4):352–9.
Erdtmann B, de Freitas AA, de Souza RP, Salzano FM. Klinefelter’s syndrome and G trisomy. J Med Genet. 1971;8(3):364–8.
Akbas E, Soylemez F, Savasoglu K, Halliogluand O, Balci S. A male case with double aneuploidy (48,XXY,+21). Genet Couns. 2008;19(1):59–63.
Gerretsen MF, Peelen W, Rammeloo LA, Koolbergen DR, Hruda J. Double aortic arch with double aneuploidy--rare anomaly in combined Down and Klinefelter syndrome. Eur J Pediatr. 2009;168(12):1479–81.
Jeanty C, Turner C. Prenatal diagnosis of double aneuploidy, 48,XXY,+21, and review of the literature. J Ultrasound Med. 2009;28(5):673–81.
Said SA, Bucx JJ, van de Weel FA. Coronary-cameral fistula in association with Klinefelter syndrome: exercise-induced ventricular tachycardia late after surgical ligation. Int J Cardiol. 1992;36(1):111–4.
Rodrigues MA, Morgade LF, Dias LFA, Moreira RV, Maia PD, Sales AFH, et al. Down-Klinefelter syndrome (48,XXY,+21) in a neonate associated with congenital heart disease. Genet Mol Res. 2017;16(3):gmr16039780.
Fricke GR, Mattern HJ, Schweikert HU, Schwanitz G. Klinefelter’s syndrome and mitral valve prolapse. an echocardiographic study in twenty-two patients. Biomed Pharmacother. 1984;38(2):88–97.
Fricke GR, Mattern HJ, Schweikert HU. Mitral valve prolapse in Klinefelter syndrome. Lancet. 1981;2(8260–61):1414.
Katsumata T, Tomizawa Y, Okoshi T, Ego Y, Iguchi N, Saigusa H, et al. [A case of Klinefelter’s syndrome with acute mitral regurgitation caused by idiopathic chordal rupture]. Kyobu Geka. 1991;44(10):867–70.
Andersen NH, Bojesen A, Kristensen K, Birkebaek NH, Fedder J, Bennett P, et al. Left ventricular dysfunction in Klinefelter syndrome is associated to insulin resistance, abdominal adiposity and hypogonadism. Clin Endocrinol (Oxf). 2008;69(5):785–91.
Pasquali D, Arcopinto M, Renzullo A, Rotondi M, Accardo G, Salzano A, et al. Cardiovascular abnormalities in Klinefelter syndrome. Int J Cardiol. 2013;168(2):754–9.
Di Mambro A, Ferlin A, De Toni L, Selice R, Caretta N, Foresta C. Endothelial progenitor cells as a new cardiovascular risk factor in Klinefelter’s syndrome. Mol Hum Reprod. 2010;16(6):411–7.
Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89(1):E1–7.
Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005;111(22):2981–7.
Salzano A, Arcopinto M, Marra AM, Bobbio E, Esposito D, Accardo G, et al. Klinefelter syndrome, cardiovascular system, and thromboembolic disease: review of literature and clinical perspectives. Eur J Endocrinol. 2016;175(1):R27–40.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sesti, F., Pofi, R., Isidori, A.M. (2020). Klinefelter Syndrome: Cardiovascular Characteristics. In: Garolla, A., Corona, G. (eds) Klinefelter’s Syndrome. Trends in Andrology and Sexual Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-51410-5_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-51410-5_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-51409-9
Online ISBN: 978-3-030-51410-5
eBook Packages: MedicineMedicine (R0)